Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer

Centre hospitalier de l'Université de Montréal (CHUM)

Status and phase

Enrolling

Phase 2

Phase 1

Conditions

Dysphagia

Treatments

Procedure: virtual group speech therapy intervention guided by a patient partner

Study type

Interventional

Funder types

Other

Identifiers

NCT05621889

2023-11195

Details and patient eligibility

About

This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer.

The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner. This intervention has the potential to improve quality of care, accessibility to services and optimize health care resources.

Enrollment

76 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adults ≥ 18 years of age with a diagnosis of head or neck cancer
Chemoradiotherapy treatments planned for curative purposes
Planned external radiation therapy dose of at least ≥60 Grays
Sufficient proficiency in French to complete self-reported questionnaires

Exclusion criteria

Remote metastases
Previous or planned total laryngectomy
Previous moderate/severe dysphagia known and/or evaluated by speech therapy
Diagnosis of a second synchronous cancer at the time of study enrollment
History of prior radiation therapy to the head and neck area
Have a cognitive impairment (diagnosed or suspected) that may significantly interfere with participation in the intervention and various measurement procedures.